Analyst Ratings for GW Pharma (GWPH)
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
2/4/2021 | H.C. Wainwright | Douglas Tsao | Downgrade | Buy (Buy) |
220.00 (N/A) |
211.37 (218.96) |
3.59% | Details |
2/4/2021 | Morgan Stanley | David Lebowitz | Downgrade | Equalweight (Overweight) |
220.00 (193.00) |
146.25 (218.96) |
49.72% | Details |